1. Home
  2. ONEW vs UNCY Comparison

ONEW vs UNCY Comparison

Compare ONEW & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$10.18

Market Cap

176.6M

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.92

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
UNCY
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.6M
145.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
ONEW
UNCY
Price
$10.18
$6.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$16.50
$25.67
AVG Volume (30 Days)
87.8K
661.2K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.77
N/A
Revenue
$1,872,334,000.00
$675,000.00
Revenue This Year
$0.30
N/A
Revenue Next Year
$3.14
$582.86
P/E Ratio
$3.92
N/A
Revenue Growth
5.62
N/A
52 Week Low
$8.12
$0.47
52 Week High
$17.92
$8.74

Technical Indicators

Market Signals
Indicator
ONEW
UNCY
Relative Strength Index (RSI) 43.23 41.89
Support Level $10.07 $6.17
Resistance Level $10.59 $7.22
Average True Range (ATR) 0.62 0.54
MACD -0.06 -0.10
Stochastic Oscillator 27.65 5.83

Price Performance

Historical Comparison
ONEW
UNCY

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: